PRDM16 identified as key regulator of human cardiomyocyte maturation

Researchers from Kyoto University and Osaka University have identified the protein PRDM16 as a key regulator in the development of human heart muscle cells (cardiomyocytes). Using human induced pluripotent stem (iPS) cell technology, the team discovered that PRDM16 functions as a developmental "rheostat."

Low levels of PRDM16 allow cardiomyocytes to maintain their ability to proliferate (divide), whereas higher levels trigger the transition toward maturation, where cells acquire the structural, metabolic, and functional traits necessary for adult cardiac function.

This finding addresses a critical challenge in regenerative medicine: the biological trade-off between a cell's ability to grow and its ability to specialize. According to researcher Kanae Tani, reducing PRDM16 levels allowed cells to regain proliferative competence, though they struggled to achieve adult-like characteristics. The study provides a potential framework for improving cardiac tissue quality for drug discovery and regenerative therapies.